Chemical Compounds
OwnerJeffrey K. Kerns, Jakob Busch-Petersen +4inventors
InventorsJeffrey K. Kerns, Jakob Busch-Petersen, Huijie Li, Jeffrey Charles Boehm, Hong Nie, John J. Taggart
Life of this patent
Estimating the term…
Abstract
The invention is directed to novel indolecarboxamide derivatives. Specifically, the invention is directed to compounds according to formula (I): where R1, R2, R3 and X are defined below. These compounds are useful in the treatment of disorders associated with inappropriate IKK2 (also known as IKKβ) activity, in particular in the treatment and prevention of disorders mediated by IKK2 mechanisms including inflammatory and tissue repair disorders. Such disorders include rheumatoid arthritis, asthma, and COPD (chronic obstructive pulmonary disease).
Claims23
A compound according to formula (I):
- wherein:
- X is O, S, S(O), S(O)2, —N(Rf), or —OC(O)O;
- R1 is H, optionally substituted C1-C8 alkyl, C1-C6 haloalkyl, optionally substituted heterocycloalkyl, optionally substituted —C1-C3 alkylene-heterocycloalkyl, optionally substituted phenyl, optionally substituted —C1-C3 alkylene-phenyl, optionally substituted naphthyl, optionally substituted —C1-C3 alkylene-naphthyl, optionally substituted heteroaryl, or optionally substituted —C1-C3 alkylene-heteroaryl,
- where said C1-C8 alkyl is optionally substituted with one substituent selected from the group consisting of:
- cyano, —NRfRf, —C(O)NRfRf, C3-C6 cycloalkyl, and C1-C6 alkoxy optionally substituted with one phenyl group;
- where said heterocycloalkyl and —C1-C3 alkylene-heterocycloalkyl are optionally substituted with one to three substituents each independently selected from the group consisting of:
- halo, hydroxyl, oxo, and C1-C6 alkyl;
- where said phenyl, —C1-C3 alkylene-phenyl, heteroaryl, and —C1-C3 alkylene-heteroaryl, are each optionally substituted with one to three substituents each independently selected from the group consisting of:
- halo, —CN, —N(Rb)SO2Re, —N(Rb)C(O)Ra, —C(O)NRaRb, —C(O)H, —SO2Ri, —NRaRb, —SO2NRaRb, —ORc, —N(Rb)C(O)NRaRb, —N(Rb)C(O)ORd, —C(O)ORa, C1-C6 alkyl, C1-C6 alkyl substituted with one to three substituents independently selected from the group consisting of:
- —NRaRb, C3-C6 cycloalkyl, phenyl, —ORc, heterocycloalkyl, and heterocycloalkyl substituted with OH, —C(O)NH2, or one or two C1-C6 alkyl groups;
- C1-C6 haloalkyl, C1-C6 haloalkyl substituted with one to three substituents each independently selected from the group consisting of —NRaRb, C3-C6 cycloalkyl, phenyl, heterocycloalkyl, and heterocycloalkyl substituted with one or two C1-C6 alkyl groups;
- heterocycloalkyl and heterocycloalkyl substituted with one or two C1-C6 alkyl groups;
- R2 is optionally substituted C1-C6 alkyl, optionally substituted aryl, optionally substituted C3-C6 cycloalkyl, optionally substituted heteroaryl, or optionally substituted heterocycloalkyl,
- wherein said C1-C6 alkyl is optionally substituted with one to three substituents each independently selected from the group consisting of:
- halo, —OR1, —NRgRh, —NHC(O)Rg, and Rj;
- and where said aryl and heteroaryl are optionally substituted with one to three substituents each independently selected from the following:
- halo, —ORg, nitro, cyano, CF3, C1-C6 alkyl, C(O)R9, COORg, —NRgRh, —NHC(O)Rg, —C(O)NRgRh, —S(O)2Rg, —NHS(O)2Rg, and —S(O)2NRgRh;
- and where said C3-C6 cycloalkyl and heterocycloalkyl are optionally substituted by one to three substituents each independently selected from the group consisting of:
- —OH, oxo, C1-C6 alkyl, and C1-C6 haloalkyl;
- R3 is one to three substituents each independently selected from the group consisting of:
- OH, oxo, C1-C6 alkyl, and C1-C6 haloalkyl;
- each Ra is independently selected from the group consisting of:
- H, optionally substituted C1-C3 alkyl, optionally substituted phenyl, optionally substituted heteroaryl, optionally substituted C3-C7 cycloalkyl, and optionally substituted heterocycloalkyl, where said C1-C3alkyl is optionally substituted with one to three substituents each independently selected from the group consisting of:
- halo, ORc, C1-C6 haloalkyl, phenyl, and heteroaryl;
- and where said phenyl, heteroaryl, C3-C7 cycloalkyl, and heterocycloalkyl are optionally substituted with one to three substituents each independently selected from the group consisting of:
- halo, ORc, C1-C6 alkyl, and C1-C6 haloalkyl;
- each Rb is independently selected from the group consisting of:
- H and optionally substituted C1-C3 alkyl, where said C1-C3 alkyl is optionally substituted with one to three ORc groups;
- each Rc is independently selected from the group consisting of:
- H, optionally substituted C1-C6 alkyl, optionally substituted C1-C6 haloalkyl, optionally substituted C3-C7 cycloalkyl, optionally substituted heterocycloalkyl, optionally substituted aryl, and optionally substituted heteroaryl, where said C1-C6 alkyl and C1-C6 haloalkyl are optionally substituted with one to three substituents each independently selected from the group consisting of:
- C3-C6 cycloalkyl, phenyl, heterocycloalkyl, and heteroaryl;
- and where said aryl and heteroaryl are optionally substituted with one to three substituents each independently selected from the group consisting of:
- halo, C1-C3 alkyl, C1-C3 haloalkyl and OH;
- and where said C3-C7 cycloalkyl and heterocycloalkyl are optionally substituted with one to three C1-C3 alkyl groups;
- each Rd is independently optionally substituted C1-C3 alkyl, where said C1-C3 alkyl is optionally substituted with one to three substituents each independently selected from the group consisting of:
- C3-C6 cycloalkyl;
- phenyl optionally substituted with one to three substituents each independently selected from the group consisting of:
- halo, C1-C6 alkyl, and C3-C6 cycloalkyl;
- and heteroaryl optionally substituted with one to three substituents each independently selected from the group consisting of:
- halo, C1-C6 alkyl, and C3-C6 cycloalkyl;
- each Re is independently selected from the group consisting of:
- optionally substituted C1-C6 alkyl, optionally substituted phenyl, optionally substituted heteroaryl, optionally substituted C5-C7 cycloalkyl, and optionally substituted heterocycloalkyl, where said C1-C6 alkyl is optionally substituted with one substituent selected from the group consisting of:
- ORc, trifluoromethyl, phenyl, heteroaryl, heterocycloalkyl optionally substituted with ORc or heterocycloalkyl, and NRaRb;
- where said phenyl and heteroaryl are optionally substituted with one to three substituents each independently selected from the group consisting of:
- halo, CN, C1-C6 alkyl, C1-C6 haloalkyl, N(Rb)C(O)Ra, and ORf;
- and where said C5-C7 cycloalkyl and heterocycloalkyl are optionally substituted with one to three substituents each independently selected from the group consisting of:
- halo, C1-C6 alkyl optionally substituted with ORc and C3-C6 cycloalkyl;
- each Rf is independently selected from the group consisting of:
- H and C1-C6 alkyl;
- each Rg is independently selected from the group consisting of:
- H, C1-C6 alkyl, C3-C6 cycloalkyl, heteroaryl, and phenyl;
- each Rh is independently selected from the group consisting of:
- H and C1-C6 alkyl optionally substituted with one phenyl group;
- each Ri is independently selected from the group consisting of:
- H, C1-C6 alkyl, C1-C6 haloalkyl, and phenyl;
- and
- Rj is optionally substituted aryl, optionally substituted heteroaryl, optionally substituted C3-C6 cycloalkyl, or optionally substituted heterocycloalkyl,
- where said aryl and heteroaryl are optionally substituted with one to three substituents each independently selected from the group consisting of:
- —ORf, nitro, cyano, CF3, C1-C6 alkyl, C(O)Rf, COORf, —NRfRg, —NHC(O)Rf, —C(O)NRfRg, —S(O)2Rf, —NHS(O)2Rf, and —S(O)2NRfRg;
- and where said C3-C6 cycloalkyl and heterocycloalkyl are optionally substituted with one to three substituents each independently selected from the group consisting of:
- —OH, oxo, C1-C6 alkyl, and C1-C6 haloalkyl;
- or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.